Emily Kaplan
MetFix
Emily Kaplan is an investigative journalist and the CEO of MetFix. Her work involves reporting on scientific corruption and examining the barriers to implementing metabolic therapies in clinical cancer care.
8 claims checked on air: 2 context 3 overstated 2 supported 1 unverified
What they said on air
A multiple myeloma study from the Dana-Farber Cancer Institute published in Blood contained duplicated/manipulated images where day 1 control group images were reused for day 16 intervention groups to claim tumor suppression.
"So they took the image from day one of the control group, and they copied and pasted it into day 16 of the intervention group and said, "Look, we have tumor suppression." So this guy Sholto David basically started looking at these images out of Dana-Farber that he said had image manipulation." (said at 0:03:11)
Multiple myeloma studies from Dana-Farber Cancer Institute researchers published in the journal *Blood* have been subject to retractions and integrity investigations regarding manipulated and duplicated figures (including in vivo xenograft tumor models). For instance, multiple papers co-authored by Dana-Farber researchers in *Blood* investigating tumor suppression and oncogenic pathways in multiple myeloma (e.g., PMID: 20962322, PMID: 19196658, PMID: 17510321) were formally retracted following investigations into data integrity and image manipulation. While the exact details of specific image manipulation claims (e.g., reusing day 1 control images for day 16 intervention groups) stem from forensic image analysis by scientific integrity sleuths (such as Sholto David) investigating Dana-Farber papers, the core factual premise regarding retracted and manipulated multiple myeloma papers in *Blood* from Dana-Farber is confirmed in the scientific record.
Nuclear transfer experiments show that normal cytoplasm/mitochondria suppress tumorigenicity even in the presence of an abnormal cancer nucleus, challenging the somatic mutation theory.
"I'm somebody who really thinks the nuclear transfer experiments are enough to rock your world. If you believe in the, you know, sort of somatic mutation theory, like that should just stop you dead in your tracks and make you say like, "Wait, how is this? This really undoes everything in the most simple, beautiful way."" (said at 0:05:13)
Nuclear-cytoplasm transfer and cybrid cell experiments demonstrate that combining a cancer nucleus with normal cytoplasm/mitochondria can suppress tumorigenic phenotypes and restore normal differentiation in cell and animal models. Proponents of the metabolic theory of cancer use these findings to challenge the prevailing somatic mutation theory. However, the available body of evidence consists primarily of in vitro cybrid assays, animal nuclear transfer studies, and narrative reviews, meaning clinical certainty remains very low.
Mitochondrial dysfunction is the common root cause of major chronic diseases including cancer, type 2 diabetes, depression, and Alzheimer's disease.
"and we know that it's mitochondrial that dictates all of the chronic diseases. You know, I often say like you go to the hospital and you get sent to the 10th floor if you have cancer, and you're sent to the fifth floor if you have type 2 diabetes, and you're out in the garden if you have depression, and you have Alzheimer's, they send you to the basement. It's the same root cause, right?" (said at 0:07:14)
While mitochondrial dysfunction is widely documented across major chronic conditions (such as type 2 diabetes, Alzheimer's disease, and cancer) and plays a key role in cellular bioenergetics and aging, claiming it is *the* single common "root cause" overstates scientific consensus. In mainstream biomedical frameworks (e.g., the Hallmarks of Aging), mitochondrial dysfunction is recognized as one of multiple interconnected hallmarks—alongside genomic instability, epigenetic alterations, loss of proteostasis, and chronic inflammation—rather than the sole initiating or unifying cause. Furthermore, the precise causal direction and etiology of mitochondrial impairment across diverse chronic pathologies remain complex, multifactorial, and actively investigated.
- context: Hallmarks of aging: An expanding universe. (Cell 2023)
"We propose the following twelve hallmarks of aging: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient-sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation, and dysbiosis. These hallmarks are interconnected among each other" (abstract, passage verified)
pubmedfull study (doi) - partial: The Key Role of Mitochondrial Function in Health and Disease. (Antioxidants (Basel, Switzerland) 2023)
"Mitochondrial dysfunction as well as disruptions of cellular bioenergetics have been shown to be ubiquitous in some of the most prevalent diseases in our society, such as type 2 diabetes, cardiovascular disease, metabolic syndrome, cancer, and Alzheimer's disease. However, the etiology and pathogenesis of mitochondrial dysfunction in multiple diseases have yet to be elucidated, making it one of the most significant medical challenges in our history." (abstract, passage verified)
pubmedfull study (doi) - context: Interactions between mitochondrial dysfunction and other hallmarks of aging: Paving a path… (Aging cell 2024)
"Indeed, preliminary results suggest that more complex interactions between aging hallmarks must be considered and addressed, if we are to develop interventions that successfully promote healthy aging and/or delay aging-associated dysfunction and diseases. Here, we summarize some of the latest work and views on the interplay between hallmarks of aging, with a specific focus on mitochondrial dysfunction." (abstract, passage verified)
pubmedfull study (doi)
Radiation and chemotherapy treatments are major risk factors for cancer recurrence and the development of secondary malignancies.
"There's no doubt about the, you know, radiation and chemotherapy being a huge risk factor for recurrence or new cancers developing. Well, if you do it in somebody 40 years younger, you're really not setting them up for a long life the way that Tom was just talking about." (said at 0:25:46)
The claim is partially accurate regarding secondary malignancies but contradicted regarding cancer recurrence. Radiotherapy and chemotherapy are well-documented risk factors for subsequent primary/secondary malignancies (such as radiation-induced solid tumors and therapy-related leukemias). However, claiming they are 'major risk factors for cancer recurrence' misrepresents their clinical role: adjuvant radiation and chemotherapy are standard therapies administered specifically to eliminate residual microscopic disease and decrease the risk of primary cancer recurrence.
- supports: Secondary malignancies after treatment of testicular germ cell tumors: a systematic review… (Journal of the National Cancer Institute 2025)
"The incidence of non-germ cell SMNs following definitive treatment of TGCTs varied by treatment modality. Surgery alone was not associated with an increased risk (SIR = 0.99, 95% confidence interval [CI] = 0.84 to 1.17); radiation (SIR = 1.66, 95% CI = 1.43 to 1.93), chemotherapy (SIR = 1.65, 95% CI = 1.39 to 1.96), and combined chemotherapy and radiation (SIR = 2.73, 95% CI = 2.23 to 3.33) were associated with a moderate to large increase in risk." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Secondary leukaemia after testicular germ cell tumour treatment: a systematic review and m… (BJU international 2026)
"Chemotherapy is associated with an increase in the relative risk of secondary leukaemias after treatment of TGCTs, although the absolute risk remains small." (abstract, conclusions, passage verified)
pubmedfull study (doi)
The average medical school curriculum provides only around 12 hours of total nutrition education.
"I mean, I think, you know, the average medical school does about like one day, 12 hours maybe at tops, looking at nutrition." (said at 0:34:45)
National surveys of accredited US medical schools report that students receive an average of approximately 19.6 to 23.9 total hours of required nutrition instruction across their medical school career (with one survey reporting 18 ± 12 hours). While nutrition education remains widely recognized as deficient and below the National Academy of Sciences recommendation of 25 hours, stating the average is 'around 12 hours' slightly understates the documented national average.
The American Medical Association generates the majority of its revenue from the licensing and sale of proprietary billing codes (CPT codes).
"No, actually they make most of their money off of billing codes. So they have proprietary billing codes they sell to insurance companies, hospitals, doctor's offices." (said at 0:57:10)
A search of biomedical databases (PubMed and Europe PMC) yielded no peer-reviewed studies or publications evaluating the specific revenue breakdown or financial auditing of the American Medical Association's licensing and sales of Current Procedural Terminology (CPT) codes. This is primarily an institutional financial/accounting matter typically disclosed in IRS Form 990 filings and annual reports rather than indexed biomedical literature. Consequently, the claim is unverified within the indexed scientific literature, which does not prove the claim false.
Virta Health has demonstrated the reversal of type 2 diabetes using dietary intervention alone in clinical trials.
"Like, you're the premier authority on diabetes, type two diabetes, and we know that you can reverse it. We've got the, you know, longest, largest trials done through Virta, just using diet." (said at 0:58:40)
Clinical trials conducted by Virta Health evaluating a continuous remote care intervention (combining telemedicine coaching and a very-low-carbohydrate ketogenic diet) demonstrated type 2 diabetes reversal and remission. In an open-label, non-randomized controlled trial, 53.5% of participants achieved diabetes reversal (defined as HbA1c <6.5% while eliminating non-metformin diabetes medications) at 2 years, with sustained reversal seen in 32.5% of 5-year completers.
Reactive oxygen species serve as cellular satiety signaling molecules that dictate fullness, with polyunsaturated fats suppressing ROS generation to promote hunger.
"And so with reactive oxygen species as a signaling molecule in the body, it dictates whether the cell is signaling that it's full or not. So when you're eating all of these polyunsaturated fats, your cells are saying, "I'm hungry. I'm hungry. Give me more." Even with high insulin and low ROS, you are looking at like I call it a double barrel shotgun in the cell where the cell is give me more, give me more." (said at 1:10:49)
Preclinical animal and cellular research demonstrates that transient mitochondrial reactive oxygen species (ROS) in hypothalamic neurons can act as nutrient-sensing signaling molecules required to suppress food intake during nutrient excess (e.g., lipid sensing). However, the assertion that polyunsaturated fatty acids (PUFAs) specifically suppress ROS generation to promote hunger is a speculative mechanistic hypothesis (often derived from theoretical biophysical models of mitochondrial electron transport) rather than an established physiological finding in humans or validated clinical trials.
Fact-checked episodes
Publications
No PubMed publication profile has been built for this speaker yet.